Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,870 | 2,705 | -2,632 | -6,270 | -4,474 |
| Depreciation Amortization | 709 | 473 | 217 | 1,020 | 827 |
| Accounts receivable | N/A | -31 | N/A | N/A | 18 |
| Other Working Capital | 5,549 | 5,653 | -459 | -910 | -1,055 |
| Other Operating Activity | 3,505 | 2,534 | 1,055 | 130 | 148 |
| Operating Cash Flow | $7,893 | $11,334 | $-1,819 | $-6,030 | $-4,536 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | 510 | 511 |
| Investing Cash Flow | $-4 | $N/A | $N/A | $510 | $511 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,462 | 1,462 | 1,462 | N/A | N/A |
| Debt Repayment | -307 | -307 | N/A | N/A | -446 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 141 |
| Other Financing Activity | 7,572 | 7,572 | -70 | 2,540 | 354 |
| Financing Cash Flow | $8,727 | $8,727 | $1,392 | $2,540 | $49 |
| Beginning Cash Position | 1,117 | 1,117 | 1,117 | 4,090 | 4,097 |
| End Cash Position | 17,733 | 21,178 | 690 | 1,110 | 121 |
| Net Cash Flow | $16,616 | $20,061 | $-427 | $-2,980 | $-3,976 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,893 | 11,334 | -1,819 | -6,030 | -4,536 |
| Capital Expenditure | -4 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 7,889 | 11,334 | -1,819 | -6,030 | -4,536 |